Biochemical Studies of CNS Receptors 1983
DOI: 10.1007/978-1-4684-4361-5_3
|View full text |Cite
|
Sign up to set email alerts
|

CNS Dopamine Receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
1

Year Published

1983
1983
2003
2003

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 24 publications
(13 citation statements)
references
References 201 publications
0
12
1
Order By: Relevance
“…To determine a reason for these differential effects of systemically administered apomorphine has been a complicated matter because the drug acts on several DA pathways, as it acts differentially at different DA subtypes. For example, apomorphine has been reported to be a full agonist at D2 receptor sites (Creese et al, 1983). Moreover, although D2 receptors are found both pre-and postsynaptically, it has been reported that the presynaptic sites are between 6 and 10 times more sensitive to apomorphine than the postsynaptic sites (Skirboll et al, 1979).…”
Section: Discussionmentioning
confidence: 99%
“…To determine a reason for these differential effects of systemically administered apomorphine has been a complicated matter because the drug acts on several DA pathways, as it acts differentially at different DA subtypes. For example, apomorphine has been reported to be a full agonist at D2 receptor sites (Creese et al, 1983). Moreover, although D2 receptors are found both pre-and postsynaptically, it has been reported that the presynaptic sites are between 6 and 10 times more sensitive to apomorphine than the postsynaptic sites (Skirboll et al, 1979).…”
Section: Discussionmentioning
confidence: 99%
“…Since it has been well documented that other neurotransmitter receptors (e.g. 13-adrenoceptors, dopaminergic receptors) are up-regulated after a long-term treatment with their respective antagonists (see Creese et al, 1983;Weiss et al, 1984), one could speculate that the increase in the density of the cortical al-adrenoceptors results from their prolonged blockade with the investigated antidepressant drugs. In fact, a moderate affinity of amitriptyline, mianserin and imipramine to brain al-adrenoceptors was reported (Hall and Ogren, 1981) and confirmed by our unpublished results (the drugs displaced [3H] prazosin in the rat cerebral cortex, the K i value being 17, 46 and 85 nM, respectively).…”
Section: Discussionmentioning
confidence: 99%
“…Of the many classifications available, the simplest system, based essentially on adenylate cyclase, holds the greatest sway at the present time for the mammalian central nervous system (Kebabian & Calne, 1979;Creese et al, 1983). In this system, DI-receptors mediate adenylate cyclase stimulation, and there is abundant evidence that SKF 38393 and SCH 23390, are, respectively, selective agonists and antagonists at DI-receptors (Setler et al, 1978;Stoof & Kebabian, 1981;Cross et al, 1983;lorio et al, 1983;O'Boyle & Waddington, 1984); in contrast, D2-receptor activation has either no effect or inhibits adenylate cyclase, and there is evidence that the compound LY 141865 is a selective agonist at this receptor site (Tsuruta et al, 1981;Stoof & Kebabian, 1981;Scatton, 1982).…”
Section: Administration Of Drugsmentioning
confidence: 99%